Source: Annual Congress 2011 - Novel clinical features of acute and chronic lung diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dmytriiev, K. Dmytriieva, K. Dmytriiev, O. Katilov, A. Staradub (Vinnitsa, Ukraine). Bronchoalveolar interleukin-1 beta: A marker of bacterial burden in children with community-acquired pneumonia (CAP). Eur Respir J 2011; 38: Suppl. 55, 2985

Member's Comments

No comment yet.

Related content which might interest you: Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia Source: Eur Respir J 2013; 41: 1378-1385 Year: 2013 Role of flexible-bronchoscopy in community-acquired pneumonia – A retrospective analysis Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Microbial investigation in ventilator-associated pneumonia Source: Eur Respir J 2001; 17: 791-801 Year: 2001 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Could procalcitonin (PCT) be a marker of effectiveness of antibiotic treatment (ABT) in pregnant with not severe community-acquired pneumonia (CAP)? Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Higher doses of inhaled steroid are associated with bacterial bronchitis in children with severe therapy resistant asthma (STRA) Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets Year: 2016 Evidence of secondary bacterial infection from bronchoalveolar lavage in children with acute bronchiolitis Source: Eur Respir J 2003; 22: Suppl. 45, 212s Year: 2003 Cryptogenic organizing pneumonia- IL1-β, IL-6, IL-8, and TGF- β concentrations in serum in patients treated with clarithromycin Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 BAL in pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 5s Year: 2006 BAL in pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 1s Year: 2006 The comparison of bronchoalveolar lavage (BAL) with mini-BAL in pneumonia developed in immunocompromised patients Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Comparison of PCR and culture based detection of pathogens in bronchoalveolar fluid in neutropenic children Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Biomarkers in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia Source: Eur Respir J 2011; 38: 1158-1164 Year: 2011 Lipoid pneumonia in infants: treatment with multiple bronchoalveolar lavages Source: Virtual Congress 2020 – Epidemiology of paediatric respiratory diseases Year: 2020 Serum procalcitonine (PCT) as a marker of respiratory infection by pseudomonas aeruginosa (PA) in patients with COPD or bronchiectasis Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 C-reactive protein in community-acquired pneumonia Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Diagnostic accuracy of inflammatory biomarkers in bronchoalveolar lavage from patients with ventilator-associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005